Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Depreciation and Depletion: 2019-2024

Historic Depreciation and Depletion for Agilon Health (AGL) over the last 6 years, with FY2024 value amounting to $12.2 million.

  • Agilon Health's Depreciation and Depletion rose 2258.06% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.4 million, marking a year-over-year increase of 3162.39%. This contributed to the annual value of $12.2 million for FY2024, which is 5250.0% up from last year.
  • According to the latest figures from FY2024, Agilon Health's Depreciation and Depletion is $12.2 million, which was up 5250.0% from $8.0 million recorded in FY2023.
  • In the past 5 years, Agilon Health's Depreciation and Depletion ranged from a high of $12.2 million in FY2024 and a low of $2.2 million during FY2020
  • For the 5-year period, Agilon Health's Depreciation and Depletion averaged around $5.7 million, with its median value being $3.9 million (2022).
  • As far as peak fluctuations go, Agilon Health's Depreciation and Depletion soared by 454.55% in 2021, and later surged by 10512.82% in 2023.
  • Annual analysis of 5 years shows Agilon Health's Depreciation and Depletion stood at $2.2 million in 2020, then increased by 4.55% to $2.3 million in 2021, then soared by 69.57% to $3.9 million in 2022, then skyrocketed by 105.13% to $8.0 million in 2023, then soared by 52.5% to $12.2 million in 2024.
  • Its Depreciation and Depletion stands at $12.2 million for FY2024, versus $8.0 million for FY2023 and $3.9 million for FY2022.